We then tested two typical AML-associated C/EBPα C-terminal mutations, the duplication of the lysine K313 (K314 in mouse, here referred to as K313) and the BRM2 mutation (I294 and R297 in humans, I295A and R298A in mouse). Here, CEBPA is linked to acute myeloid leukemia.